Anavex Life Sciences Corp. (AVXL)

NASDAQ: AVXL · Real-Time Price · USD

4.100

+0.290 (7.61%)

At close: Feb 6, 2026, 4:00 PM EST

4.250

+0.150 (3.66%)

After-hours: Feb 6, 2026, 7:58 PM EST

Anavex Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 6, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	366	764	482	537	804	1,359
Market Cap Growth	-57.65%	58.72%	-10.27%	-33.27%	-40.83%	396.34%
Enterprise Value	264	663	343	382	651	1,202
Last Close Price	4.10	8.90	5.68	6.55	10.32	17.95
PB Ratio	3.75	8.06	4.01	3.78	5.65	9.01
P/TBV Ratio	3.86	8.06	4.01	3.78	5.65	9.01
Quick Ratio	11.56	11.56	8.80	12.27	14.92	14.93
Current Ratio	11.61	11.61	8.86	12.32	14.95	14.97
Return on Equity (ROE)	-43.11%	-43.11%	-32.81%	-33.41%	-32.71%	-42.58%
Return on Assets (ROA)	-26.51%	-26.51%	-21.81%	-21.59%	-18.95%	-23.87%
Return on Capital Employed (ROCE)	-53.50%	-53.50%	-42.10%	-37.40%	-33.40%	-24.80%
Earnings Yield	-12.66%	-6.07%	-8.93%	-8.85%	-5.96%	-2.79%
Buyback Yield / Dilution	-2.18%	-2.18%	-4.61%	-3.74%	-10.18%	-19.95%

Updated Nov 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q